Organisation
Hematology
Current researchers
1 - 10 of 18 results
- Fatema Afennas (Member)
- Veerle Beckers (Member)
- Charlotte Caron (Member)
- Ludwine Antoinette Claeys (Member)
- Ann De Becker (Member)
- Nathan De Beule (Member)
- Inke De Haes (Member)
- Sylvia Faict (Member)
- Karel Fostier (Member)
- Kristin Jochmans (Member)
Projects
1 - 1 of 1
- Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsiesFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
Publications
1 - 10 of 79
- Haemophagocytic lymphohistiocytosis during pregnancy: a case presentation and literature review(2022)
Authors: Larissa Fávero Vanraes, Veerle Beckers, Kim Van Berkel, Leonardo Gucciardo, Gilles Faron
- Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1)(2022)
Authors: Meletios A Dimopoulos, Paul G Richardson, Nizar J Bahlis, Sebastian Grosicki, Michele Cavo, Meral Beksaç, Wojciech Legieć, Anna M Liberati, Hartmut Goldschmidt, Andrew Belch, et al.
Pages: 403-414 - Mesenchymal stem cells in multiple myeloma(2018)
Authors: Song Xu, Kim De Veirman, Ann De Becker, Karin Vanderkerken, Ivan Van Riet
Pages: 1500-1514 - COVID-19, impact on myeloma patients(2020)
Authors: Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, Pauline Storms, Caroline Jacquy, Ann Van de Velde, Philippe Mineur, et al.
Pages: 1947-1949 - Immunomodulatory drugs: new developments(2013)
Authors: Karel Fostier
Pages: 21-28 - Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Authors: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pages: 599-611 - Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals(2022)
Authors: Jana Vanden Broeck, Katrien Beeckman, Evelyne Van Gastel, Luc De Keersmaecker, Timothy Devos, Christiane Gérard, Lucien Noens, Dominique Putzeys, Karin Van Poucke, Margareta Haelterman, et al.
Pages: 259-267 - A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors(2019)
Authors: Jeroen M.K. de Filette, Corina Andreescu, Filip Cools, Bert Bravenboer, Brigitte Velkeniers-Hoebanckx
Pages: 145-156 - Leptomeningeal metastasis in a marginal zone lymphoma, presenting as a delirium(2020)
Authors: Lisa Dreessen, Nicolas Maréchal, Michel Louisa Verheyden, Ann De Becker, Kristin Jochmans, Tim Vanderhasselt, Bert Bravenboer, Ingo Beyer
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19(2020)
Authors: Robert L Hoffman, Robert S Kania, Mary A Brothers, Jay F Davies, Rose A Ferre, Ketan S Gajiwala, Mingying He, Robert J Hogan, Kirk Kozminski, Lilian Y Li, et al.
Pages: 12725-12747